Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
33626L.KS Stock Summary
Top 10 Correlated ETFs
33626L.KS
In the News
33626L.KS Financial details
Company Rating
Sell
Market Cap
1391.46B
Income
-8.5B
Revenue
260.89B
Book val./share
6264.71
Cash/share
630.24
Dividend
-
Dividend %
-
Employees
467
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
169.14
Forward P/E
-
PEG
-8.99
P/S
5.14
P/B
2.06
P/C
12.68
P/FCF
-4.34
Quick Ratio
-
Current Ratio
2.06
Debt / Equity
0.74
LT Debt / Equity
0.38
-
-
EPS (TTM)
-108.48
EPS next Y
-
EPS next Q
-
EPS this Y
-187.69%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.36%
Revenue Q/Q
154.86%
EPS Q/Q
991.8%
-
-
-
-
SMA20
-9.7%
SMA50
-20.29%
SMA100
-0.6%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.03%
Gross Margin
20%
Oper. Margin
9%
Profit Margin
2%
Payout
-
Shs Outstand
174.27M
Shs Float
108.21M
-
-
-
-
Target Price
-
52W Range
7700.0-12500.0
52W High
-36.08%
52W Low
+3.77%
RSI
25.3
Rel Volume
0.72
Avg Volume
1.64K
Volume
1.18K
Perf Week
-3.73%
Perf Month
-12.2%
Perf Quarter
-11.91%
Perf Half Y
-13.25%
-
-
-
-
Beta
2.401
-
-
Volatility
152.38%, 389.37%
Prev Close
0.13%
Price
7990
Change
0.13%
33626L.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.16K | 6.67K | 4.84K | 9.93K | 3.31K | |
Net income per share | 169.37 | 204.95 | 110.27 | 122.94 | -107.81 | |
Operating cash flow per share | 1.74K | -1.1K | -1.78K | -8.2K | 98.58 | |
Free cash flow per share | 1.73K | -1.29K | -2.29K | -10.65K | -1.36K | |
Cash per share | 2.19K | 5.67K | 2.37K | 1.61K | 654.11 | |
Book value per share | 2.38K | 7.4K | 6.57K | 16.64K | 6.5K | |
Tangible book value per share | 1.97K | 7K | 6.1K | 15.5K | 6.07K | |
Share holders equity per share | 2.38K | 7.4K | 6.57K | 16.64K | 6.5K | |
Interest debt per share | 1.46K | 1.53K | 1.14K | 9K | 5.04K | |
Market cap | 848.06B | 1360.49B | 1364.15B | 370.84B | 804.23B | |
Enterprise value | 815.86B | 1329.35B | 1442.83B | 616.78B | 1138.16B | |
P/E ratio | 71.44 | 95.88 | 156.89 | 95.98 | -94.61 | |
Price to sales ratio | 3.83 | 2.95 | 3.58 | 1.19 | 3.08 | |
POCF ratio | 6.97 | -17.89 | -9.74 | -1.44 | 103.47 | |
PFCF ratio | 6.99 | -15.18 | -7.57 | -1.11 | -7.49 | |
P/B Ratio | 5.09 | 2.65 | 2.63 | 0.71 | 1.57 | |
PTB ratio | 5.09 | 2.65 | 2.63 | 0.71 | 1.57 | |
EV to sales | 3.69 | 2.88 | 3.78 | 1.98 | 4.36 | |
Enterprise value over EBITDA | 43.07 | 41.14 | 47.42 | 24.62 | 61.38 | |
EV to operating cash flow | 6.7 | -17.48 | -10.3 | -2.39 | 146.43 | |
EV to free cash flow | 6.72 | -14.83 | -8 | -1.84 | -10.59 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | |
Free cash flow yield | 0.14 | -0.07 | -0.13 | -0.9 | -0.13 | |
Debt to equity | 0.61 | 0.2 | 0.16 | 0.53 | 0.74 | |
Debt to assets | 0.2 | 0.13 | 0.12 | 0.27 | 0.35 | |
Net debt to EBITDA | -1.7 | -0.96 | 2.59 | 9.82 | 18.01 | |
Current ratio | 1.81 | 2.46 | 6.42 | 2.16 | 2.26 | |
Interest coverage | 15.05 | 5.25 | 3.57 | 2.58 | 0.18 | |
Income quality | 10.26 | -5.36 | -16.11 | -66.69 | -0.91 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.83 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.01 | 0.01 | 0.03 | 0.03 | |
Research and developement to revenue | 0 | 0.01 | 0.01 | 0.02 | 0.01 | |
Intangibles to total assets | 0.06 | 0.04 | 0.05 | 0.04 | 0.03 | |
Capex to operating cash flow | 0 | 0.18 | 0.29 | 0.3 | -14.82 | |
Capex to revenue | 0 | -0.03 | -0.11 | -0.25 | -0.44 | |
Capex to depreciation | -0.24 | -1.86 | -4.65 | -6.26 | -7.48 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.01K | 5.84K | 4.04K | 6.79K | 3.97K | |
ROIC | 0.05 | 0.03 | 0.01 | 0.01 | 0 | |
Return on tangible assets | 0.03 | 0.02 | 0.01 | 0 | -0.01 | |
Graham Net | -56.23 | 4.05K | 2.35K | -2.94K | -2.46K | |
Working capital | 183.06B | 387.41B | 420.62B | 363.05B | 360.7B | |
Tangible asset value | 138.17B | 484.57B | 480.91B | 487.05B | 478.43B | |
Net current asset value | 79.37B | 374.34B | 317.57B | 171.85B | 89.88B | |
Invested capital | 0.61 | 0.2 | 0.16 | 0.53 | 0.74 | |
Average receivables | 0 | 161.5B | 122.76B | 146.8B | 151.76B | |
Average payables | 0 | 58.61B | 45.48B | 51.3B | 58.08B | |
Average inventory | 0 | 94.95B | 160.63B | 319.87B | 445.41B | |
Days sales outstanding | 292.47 | 115.21 | 95.46 | 226.68 | 153.43 | |
Days payables outstanding | 80.64 | 65.7 | 18.55 | 116.9 | 49.34 | |
Days of inventory on hand | 144.96 | 99.63 | 228.95 | 587.79 | 744.27 | |
Receivables turnover | 1.25 | 3.17 | 3.82 | 1.61 | 2.38 | |
Payables turnover | 4.53 | 5.56 | 19.68 | 3.12 | 7.4 | |
Inventory turnover | 2.52 | 3.66 | 1.59 | 0.62 | 0.49 | |
ROE | 0.07 | 0.03 | 0.02 | 0.01 | -0.02 | |
Capex per share | -5.54 | -196.55 | -510.59 | -2.46K | -1.46K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.46K | 463.66 | 457.01 | 578.32 | 1.42K | |
Net income per share | 52.14 | 17.36 | -2.64 | -10.37 | -113.22 | |
Operating cash flow per share | -509.06 | -248.24 | -406.32 | 624.76 | 353.8 | |
Free cash flow per share | -725.81 | -603.05 | -678.75 | 158.01 | 220.54 | |
Cash per share | 471.5 | 231.05 | 539.4 | 273.89 | 630.24 | |
Book value per share | 4.86K | 4.88K | 4.88K | 6.65K | 6.26K | |
Tangible book value per share | 4.53K | 4.56K | 4.56K | 6.22K | 5.85K | |
Share holders equity per share | 4.86K | 4.88K | 4.88K | 6.65K | 6.26K | |
Interest debt per share | 2.6K | 2.98K | 3.98K | 4.81K | 4.69K | |
Market cap | 1269.82B | 1287.04B | 1129.93B | 733.26B | 834.68B | |
Enterprise value | 1515.76B | 1597.51B | 1495.98B | 1086.1B | 1168.62B | |
P/E ratio | 56.58 | 172.26 | -992.45 | -224.12 | -22.52 | |
Price to sales ratio | 8.08 | 25.79 | 22.98 | 16.08 | 7.18 | |
POCF ratio | -23.18 | -48.18 | -25.84 | 14.89 | 28.83 | |
PFCF ratio | -16.26 | -19.83 | -15.47 | 58.86 | 46.25 | |
P/B Ratio | 2.43 | 2.45 | 2.15 | 1.4 | 1.63 | |
PTB ratio | 2.43 | 2.45 | 2.15 | 1.4 | 1.63 | |
EV to sales | 9.64 | 32.02 | 30.42 | 23.82 | 10.06 | |
Enterprise value over EBITDA | 78.57 | 150.97 | 157.75 | 108.11 | 1.38K | |
EV to operating cash flow | -27.67 | -59.8 | -34.21 | 22.05 | 40.36 | |
EV to free cash flow | -19.41 | -24.62 | -20.48 | 87.18 | 64.75 | |
Earnings yield | 0 | 0 | 0 | 0 | -0.01 | |
Free cash flow yield | -0.06 | -0.05 | -0.06 | 0.02 | 0.02 | |
Debt to equity | 0.53 | 0.6 | 0.81 | 0.71 | 0.74 | |
Debt to assets | 0.27 | 0.31 | 0.38 | 0.35 | 0.35 | |
Net debt to EBITDA | 12.75 | 29.34 | 38.6 | 35.12 | 395.08 | |
Current ratio | 2.16 | 2.16 | 2.65 | 2.06 | 2.26 | |
Interest coverage | 8.97 | 1.95 | 0.11 | 0.13 | -0.6 | |
Income quality | -9.76 | -14.3 | 153.62 | -60.22 | -3.12 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.18 | 0.21 | 0.02 | |
Research and developement to revenue | 0.02 | 0.03 | 0.02 | 0.01 | 0.01 | |
Intangibles to total assets | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | 0.43 | 1.43 | 0.67 | -0.75 | -0.38 | |
Capex to revenue | -0.15 | -0.77 | -0.6 | -0.81 | -0.09 | |
Capex to depreciation | -5.95 | -10.1 | -7.48 | -8.81 | -3.09 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.39K | 1.38K | 538.93 | 1.25K | 3.99K | |
ROIC | 0.02 | 0.01 | 0 | 0 | 0 | |
Return on tangible assets | 0.01 | 0 | 0 | 0 | -0.01 | |
Graham Net | -858.34 | -1.13K | -1.72K | -2.76K | -2.37K | |
Working capital | 363.05B | 341.13B | 427.02B | 317.81B | 360.7B | |
Tangible asset value | 487.05B | 490.2B | 490.65B | 490.15B | 478.43B | |
Net current asset value | 171.85B | 149.4B | 95.5B | 59.34B | 89.88B | |
Invested capital | 0.53 | 0.6 | 0.81 | 0.71 | 0.74 | |
Average receivables | 179.99B | 165.93B | 135.99B | 108.44B | 96.29B | |
Average payables | 87.11B | 66.68B | 40.36B | 32.37B | 31.1B | |
Average inventory | 423.4B | 451.65B | 483.22B | 502.8B | 485.92B | |
Days sales outstanding | 111 | 248.93 | 245.18 | 163.64 | 84.93 | |
Days payables outstanding | 60.13 | 116.48 | 74.9 | 80.25 | 24.8 | |
Days of inventory on hand | 302.35 | 1.15K | 1.12K | 1.3K | 374.03 | |
Receivables turnover | 0.81 | 0.36 | 0.37 | 0.55 | 1.06 | |
Payables turnover | 1.5 | 0.77 | 1.2 | 1.12 | 3.63 | |
Inventory turnover | 0.3 | 0.08 | 0.08 | 0.07 | 0.24 | |
ROE | 0.01 | 0 | 0 | 0 | -0.02 | |
Capex per share | -216.75 | -354.8 | -272.43 | -466.75 | -133.26 |
33626L.KS Frequently Asked Questions
What is Doosan Fuel Cell America, Inc. stock symbol ?
Doosan Fuel Cell America, Inc. is a KR stock and trading under the symbol 33626L.KS
What is Doosan Fuel Cell America, Inc. stock quote today ?
Doosan Fuel Cell America, Inc. stock price is $7990 today.
Is Doosan Fuel Cell America, Inc. stock public?
Yes, Doosan Fuel Cell America, Inc. is a publicly traded company.